An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...

In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.

Using a historical data set from UT MD Anderson, Path-IO separated patients into high-risk and low-risk groups. Patients in ...

With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...

Researchers at AACR shared data on their model's ability to predict which NSCLC patients are likely to respond to ...